Page last updated: 2024-08-25

5-hydroxymethylcytosine and Myelodysplastic Syndromes

5-hydroxymethylcytosine has been researched along with Myelodysplastic Syndromes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, S; Liu, X; Luo, Y; Pei, M; Shen, J; Xiao, L; Xu, Y; Yi, Y; Zhang, G; Zheng, W; Zhong, H1
Calvo, X; Costa, D; Esteve, J; Monzó, M; Muñoz, C; Navarro, A; Nomdedeu, B; Nomdedeu, M; Peña, O; Pereira, A; Risueño, RM; Tejero, R1
Abdelhay, E; Batalha, AB; Boulhosa, AM; Bueno, AP; Coutinho, DF; Fernandez, TS; Gutiyama, LM; Monte-Mór, BC; Pombo-de-Oliveira, MS; Rouxinol, ST; Vianna, DT; Zalcberg, IR1
Kriaucionis, S; McClellan, M; Schuster-Boeckler, B; Tomkova, M1

Other Studies

4 other study(ies) available for 5-hydroxymethylcytosine and Myelodysplastic Syndromes

ArticleYear
Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:11

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Prognosis; Proto-Oncogene Proteins; Young Adult

2013
High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome.
    Leukemia research, 2014, Volume: 38, Issue:8

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Bone Marrow; Cytosine; DNA; DNA Methylation; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Survival Analysis

2014
TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood.
    Leukemia research, 2015, Volume: 39, Issue:10

    Topics: 5-Methylcytosine; Adolescent; Case-Control Studies; Child; Child, Preschool; Cytosine; Dioxygenases; DNA Mutational Analysis; DNA-Binding Proteins; Female; Gene Expression Regulation; High-Throughput Nucleotide Sequencing; Humans; Infant; Male; MicroRNAs; Mutation; Myelodysplastic Syndromes; Polymerase Chain Reaction; Proto-Oncogene Proteins; Transcriptome

2015
5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
    eLife, 2016, 05-16, Volume: 5

    Topics: 5-Methylcytosine; Brain Neoplasms; CpG Islands; Databases, Genetic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Exome Sequencing; Humans; Kidney Neoplasms; Mutation Rate; Myelodysplastic Syndromes; Myeloid Cells

2016